Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction?

J Thorac Oncol. 2022 Mar;17(3):e35-e38. doi: 10.1016/j.jtho.2021.08.018.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenosine / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • ErbB Receptors / therapeutic use
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Oncogene Addiction

Substances

  • EGFR protein, human
  • ErbB Receptors
  • Adenosine